Drug Carbonic Anhydrase Inhibitor

Keveyis

Payments companies reported to CMS as associated with Keveyis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$148Kassociated payments (2023-2025)
4,613clinicians with associated payments
1company reporting

By year

2023 $40K
2024 $47K
2025 $61K

Payments reported as associated with Keveyis, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Family Medicine $32K
Family $26K
Neurology (Psychiatry & Neurology) $18K
Internal Medicine $17K
Physician Assistant $13K
Nephrology (Internal Medicine) $8,163

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Keveyis

These are the largest totals companies reported as associated with Keveyis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Albert Marano Johnston, RI Neurology (Psychiatry & Neurology) $379.58
Brittany Stuart Brooklyn, NY Physician Assistant $377.96
Tina Joyce Concord Twp, OH Family Medicine $368.14
Jeremias Ramos Live Oak, TX Family $319.84
Susan Shin New York, NY Neurology (Psychiatry & Neurology) $316.11
David Simpson New York, NY Neurology (Psychiatry & Neurology) $304.91
Heather Miles Live Oak, TX Family $296.51
Hamid Sami Meriden, CT Neurology (Psychiatry & Neurology) $289.06
Brittany Bertone Johnston, RI Physician Assistant $264.84
Kevin Felice New Britain, CT Neuromuscular Medicine (Psychiatry & Neurology) $261.76

Prescribed Keveyis?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.